Cargando…
The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
Objective: Diabetic kidney disease (DKD) has become the major cause of end-stage renal disease (ESRD) associated with the progression of renal fibrosis. As gut microbiota dysbiosis is closely related to renal damage and fibrosis, we investigated the role of gut microbiota and microbiota-related seru...
Autores principales: | Zhang, Qing, Zhang, Yanmei, Zeng, Lu, Chen, Guowei, Zhang, La, Liu, Meifang, Sheng, Hongqin, Hu, Xiaoxuan, Su, Jingxu, Zhang, Duo, Lu, Fuhua, Liu, Xusheng, Zhang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652004/ https://www.ncbi.nlm.nih.gov/pubmed/34899312 http://dx.doi.org/10.3389/fphar.2021.757508 |
Ejemplares similares
-
Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
por: Zhang, Bo, et al.
Publicado: (2022) -
The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
por: Huang, Yinghui, et al.
Publicado: (2022) -
Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats
por: Ji, Chunlan, et al.
Publicado: (2021) -
Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics
por: Xu, Hui, et al.
Publicado: (2022) -
Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
por: Wang, Dongmei, et al.
Publicado: (2022)